Valeant Pharmaceuticals (VRX) has agreed to acquire Obagi Medical Products (OMPI) for $360M,...

|About: Valeant Pharmaceuticals I... (VRX)|By:, SA News Editor

Valeant Pharmaceuticals (VRX) has agreed to acquire Obagi Medical Products (OMPI) for $360M, with the $19.75/share offer representing a 42% premium to Obagi's closing price on Thursday last week, a day before it released its 2012 earnings results. (PR)